Staveren, I.L. van

cancer patient breast tumor expression response level breast cancer tamoxifen mutation therapy study analysis ezh 2 treatment protein status factor chemotherapy adjuvant survival disease association ratio resistance value prognostic table tp 53 carcinoma tamoxifen therapy multivariate analysis breast cancer patients tamoxifen treatment receptor multivariate tp 53 mutation expression levels 1.00 methylation month signi ficantly breast tumors mmr inactivation hoxb 13 hoxb 13-to ratio tissue 13-to model signi ecm genes estrogen result microsatellite cancer cell lines tp 53 gene prognosis microsatellite instability growth sparc er-positive specimen first-line inactivation prognostic value tumor characteristics range number group ezh 2 levels mrna expression levels cell lines sample platinum-based chemotherapy tp 53 mutations timp 3 cutoff point monotherapy marker